Abstract
(84, 76 and 67%) was significantly higher than the respective values in the dialysis group (83, 69, and Between January 1980 and December 1995, a total of 1715 56%). Within the live donor recipient cohort the sur-kidney transplant operations were performed in our centre. vival advantage for the pre-emptive group was even First kidney transplants numbered 1463, of which 1345 were more striking. from cadavers and 118 from live donors. No patients were excluded from the analysis. Among the 1463 primary alloConclusion. Pre-emptive kidney transplantation not graft recipients there were 161 pre-emptive kidney transonly avoids the risks, cost, and inconvenience of diaplants. For this study PKT was defined as any kidney lysis, but is also associated with better graft survival transplant performed before commencement of dialysis. This than transplantation after a period of dialysis, particugroup was compared with the group of 1302 patients who larly within the live donor cohort.
were transplanted after being established on dialysis. A separate analysis for the cadaver and live donor transplant received azathioprine in combination with prednisolone. Outcomes Subsequently, a triple regimen was instituted composed of The number of patients ( Table 2 ) with a single rejection azathioprine, prednisolone, and cyclosporin (CsA). This was was higher in the pre-emptive group (37 vs 30%). The eventually replaced with our monotherapy protocol of CsA number of patients with more than one rejection was in an initial dose of 15 mg/kg with later dosage adjusted according to trough levels. During the 'monotherapy era' also higher in the pre-emptive group [30% vs 25%) recipients with delayed graft function still received initially a resulting in an overall incidence of rejection of 67% in triple drug regimen (CsA at 5 mg per kg, prednisolone 20 mg, the pre-emptive group in comparison with 55% in the and azathioprine 2 mg per kg). Acute rejection episodes dialysis group (P=0.02).
were treated with high-dose intravenous methylprednisolone Graft survival for all first grafts is shown in Figure 1 account for the possible influence of a greater number of living donor transplants in the pre-emptive group, Outcomes cadaver transplants were further analysed separately. The actuarial graft survival for the cadaver kidneys The primary outcome was the occurrence of graft failure only ( Figure 2 ) appears to be the same in the first few from any cause, including death with a functioning graft. years for both groups. However, graft survival in the Secondary outcomes were the number of rejection episodes pre-emptive group exceeds that of the post-dialysis in the two groups and the serum creatinine values in patients group so that at 5 years it is 71.8 vs 64.4% and at 10 with functioning grafts.
years from transplantation is 63 vs 54.5% shown in the post-dialysis group respectively. The patients still at Statistical analysis risk at the end of 9th year were 285 in the post-dialysis group and 28 in the pre-dialysis group. Although this Patient and graft survival was calculated by Kaplan-Meier does not reach statistical significance, the trend is quite life table analysis and statistical significance of the differences apparent.
was assessed by the log-rank test. The chi-squared test was Analysis of living related transplants reveals striking used to compare the incidence of categorical values between differences ( Figure 3 recipients at risk at the end of 4 years are 57 in the post-dialysis group and 18 in the pre-emptive group.
Within the cadaver group, pre-emptive transplanta-
Results
tion resulted in a slightly higher patient survival at 1, 5, and 10 years (95, 91.7 and 82% respectively) comOver a period of 16 years, 1463 primary renal allograft pared to that for the dialysis group (94, 86.7 and procedures were performed in our centre. One hundred 73.6%). Although the survival curves continue to and sixty-one (11%) of these transplant operations diverge with increasing time from transplantation, the were pre-emptive. The remaining 1302 (89%) patients, difference does not achieve statistical significance. the post-dialysis group, were transplanted after having Median serum creatinines in the surviving grafts of been treated by haemodialysis or CAPD for a variable both post-dialysis and pre-emptive groups were the period of time. The post-dialysis and pre-emptive same. groups of patients were comparable in respect of mean age, primary cause of renal failure, donor and recipient gender, female donor to male recipient ratio, cold Discussion ischaemic time, and degree of HLA mismatch ( Table 1) . Delayed graft function was more frequent in the post-dialysis group (24.5 vs 16%, P=0.014). This analysis demonstrates that pre-emptive transplantation can be associated with improved graft, and There were more patients with a peak panel reactive antibody level (PRA) of less than 5% in the pre-slightly better patient, survival than conventional postdialysis transplantation. The two groups of patients in emptive group (77.5 vs 65.2%, P=0.002); the percentage of patients who had received blood transfusion this study were well matched for the major pretransplant variables with the exception of graft origin; prior to transplantation was higher within the postdialysis group compared to that in the pre-emptive the pre-emptive group received a higher proportion of living donor allografts. This was a direct result of our group (P<0.001) and there were significantly more living donor transplant recipients in the pre-emptive policy to actively encourage living donors to donate pre-emptively. It is possible that this approach may group (14.2 vs 7.3%). The analysis was done for all first transplants as well as separately for cadaver and have given a misleading impression of the outcome in the pre-emptive group; our separate analysis of cadaver living donor transplants. grafts pre-emptively. The size of our study group, the largest reported, makes it a valuable source of informa-
tion. The Oxford group demonstrated a survival advantage in the pre-emptive group that was mainly and live donor grafts has addressed this question of due to better patient survival [7] . This present study potential bias. In the group of patients receiving cada-shows that the slightly better graft survival of the prever grafts, divergence of the graft survival curves for emptive group is not solely explained by better patient post-dialysis and pre-emptive recipients is apparent by survival. 5 years post-transplantation and the difference in surOur study has confirmed that rejection rate is higher in the pre-emptive group. It has been suggested that vival continues to increase thereafter. This observation this may be due to either poor drug compliance or to pulation of living donor grafts, pre-emptive transplantation increases graft survival to a marked degree. the absence of the immunosuppressive effect of the uraemic state [6 ] . The design of our study did not This phenomenon is not readily explained, but might be due to both reduced cardiovascular risk as well as allow us to reach a firm conclusion for the cause of this phenomenon, although in the cyclosporin era, a higher degree of motivation and absence of concurrent illnesses in the pre-dialysis group. We therefore when drug levels have been regularly monitored, we have not been aware of any overt difference in compli-suggest that this approach should be adopted as policy in all units wherever possible. ance between the two groups. The possibility that a blood transfusion effect is in operation could also not In these circumstances of living donation there is no ethical dilemma, which might otherwise exist in respect be excluded, since the post-dialysis group had been transfused more frequently and had higher peak react-of cadaveric transplantation. In the cadaveric situation it can be argued that such a policy results in the ive antibodies prior to transplantation. It is important to note, though, that the higher rate of rejection in the diversion of a scarce resource from patients who have been established on dialysis to patients who have not pre-emptive group did not lead to a greater incidence of acute graft loss.
been through the experience at all [9] . A small difference in graft and patient survival along with the In our unit 10.3% of the cadaver transplants are performed pre-emptively, a rate that is higher than in avoidance of the cost of dialysis needs to be balanced against the increased cost resulting from higher rejecmost units around the world (which varies from virtually 0% in Germany to 7.6% in Minnesota, with an tion rates and the ethical problems involved.
The policy adopted in our unit has resulted in a overall reported rate of 2%) [8] .
We have shown unequivocally that within the subpo-relatively high rate (19.5%) of pre-emptive living
